Hellebrekers B W, Zwinderman A H, Kenter G G, Peters A A, Fleuren G J, Trimbos J B
Afd. Gynaecologie: B.W.J. Hellebrekers, Leids Universitair Medisch Centrum, Postbus 9600, 2300 RC Leiden.
Ned Tijdschr Geneeskd. 2000 Nov 25;144(48):2304-9.
To analyse local tumour parameters of early cervical cancer that might be of prognostic significance for tumour relapse in the pelvis.
Retrospective.
Data were collected from 308 patients who underwent radical hysterectomy and pelvic lymphadenectomy in the years 1984-1996 in the Leiden University Medical Centre, the Netherlands. Treatment policies and operating staff were the same during the study period. The existence of relapse was studied by physical, gynaecological, laboratory and, if indicated, radiological examination.
Data on 294 patients were available for analysis. Their mean age was 45 years (range: 21-82). Postoperative radiation treatment was given to 119 patients (40%). Mean follow-up duration was 36 months (range: 1-136). Recurrences had developed in 46 patients (15.6%), 29 of whom had died. The calculated overall 5-year survival rate was 83%; 91% for those with negative and 53% for those with positive pelvic nodes. The calculated recurrence-free-5-year survival rate was 75% for the entire group, 83% for the patients without and 47% for those with lymph node metastases. When more than one lymph node region was affected, 5-year disease free survival was 19% and when lymph node metastasis occurred bilaterally, it was 22%. Multivariate analysis revealed that lymph node involvement (hazard ratio: 4.4), parametrial involvement (5.5), tumour size > 30 mm (4.6) and depth of invasion > 10 mm (5.1) were independent factors of prognostic significance for disease free survival. The current indications for adjuvant treatment might be extended with infiltration depth. The number and the bilaterality, if any, of affected lymph node stations might be indication for additional adjuvant therapy.
分析早期宫颈癌的局部肿瘤参数,这些参数可能对盆腔肿瘤复发具有预后意义。
回顾性研究。
收集了1984年至1996年在荷兰莱顿大学医学中心接受根治性子宫切除术和盆腔淋巴结清扫术的308例患者的数据。研究期间治疗策略和手术人员相同。通过体格检查、妇科检查、实验室检查以及必要时的放射学检查来研究复发情况。
有294例患者的数据可供分析。她们的平均年龄为45岁(范围:21 - 82岁)。119例患者(40%)接受了术后放疗。平均随访时间为36个月(范围:1 - 136个月)。46例患者(15.6%)出现复发,其中29例死亡。计算得出的总体5年生存率为83%;盆腔淋巴结阴性者为91%,阳性者为53%。整个组计算得出的无复发生存率为75%,无淋巴结转移患者为83%,有淋巴结转移患者为47%。当不止一个淋巴结区域受累时,5年无病生存率为19%,当双侧发生淋巴结转移时,为22%。多因素分析显示,淋巴结受累(风险比:4.4)、宫旁组织受累(5.5)、肿瘤大小>30 mm(4.6)和浸润深度>10 mm(5.1)是无病生存的独立预后因素。目前辅助治疗的指征可能随着浸润深度而扩大。受累淋巴结站的数量及双侧情况(如有)可能是额外辅助治疗的指征。